Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Qingsong Liu, Jing Yang et al.|Signal Transduction and Targeted Therapy|2023Cited by 46